[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-RZLT":3,"homepage-market-summary":31,"stock-news-RZLT":175},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"RZLT","2026-10-08",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Rezolute, Inc. Common Stock (NV)","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.","58","Redwood City, CA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},4.64,4.33,4.685,4.32,4.38,0.26,5.94,2197519.607327,14828,4.5787,11.457,1.07,3146032.390078339,34.4,3455,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":154},"success",[34,41,48,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":14,"sparkline":40,"date":5},"SPX","S&P 500",7765.36,-36.41,-0.47,"0.0,10.5 2.3,12.4 4.6,14.2 6.9,16.0 9.3,11.5 11.6,10.8 13.9,4.8 16.2,4.8 18.5,7.9 20.8,8.0 23.2,6.0 25.5,9.1 27.8,9.8 30.1,10.8 32.4,10.0 34.7,7.0 37.1,4.4 39.4,2.0 41.7,2.9 44.0,4.8",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":14,"sparkline":47,"date":5},"NDX","NASDAQ 100",30725.81,-434.27,-1.39,"0.0,13.4 2.3,14.8 4.6,16.0 6.9,16.0 9.3,12.9 11.6,11.7 13.9,6.5 16.2,5.0 18.5,6.6 20.8,6.6 23.2,5.8 25.5,7.8 27.8,7.4 30.1,7.0 32.4,6.4 34.7,4.6 37.1,2.9 39.4,2.0 41.7,2.4 44.0,5.1",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":54,"sparkline":55,"date":5},"DJI","DOW JONES",51232,52,0.1,true,"0.0,2.0 2.3,3.3 4.6,6.0 6.9,11.3 9.3,8.7 11.6,9.5 13.9,6.4 16.2,8.0 18.5,10.9 20.8,12.3 23.2,8.2 25.5,11.2 27.8,12.3 30.1,16.0 32.4,15.8 34.7,13.7 37.1,13.0 39.4,10.8 41.7,13.7 44.0,13.3",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":14,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27193.34,-345.35,-1.25,"0.0,12.9 2.3,14.2 4.6,16.0 6.9,16.0 9.3,12.2 11.6,11.3 13.9,6.1 16.2,5.1 18.5,7.7 20.8,7.7 23.2,6.6 25.5,8.7 27.8,8.9 30.1,8.4 32.4,8.3 34.7,5.5 37.1,3.1 39.4,2.0 41.7,2.5 44.0,5.5",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":14,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2775.7,-1.3,-0.05,"0.0,2.0 2.3,4.1 4.6,6.6 6.9,8.1 9.3,6.3 11.6,7.9 13.9,6.1 16.2,4.1 18.5,10.6 20.8,10.9 23.2,10.6 25.5,13.0 27.8,14.2 30.1,15.6 32.4,14.2 34.7,11.1 37.1,8.8 39.4,11.3 41.7,15.8 44.0,16.0",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":54,"sparkline":76,"date":5},"VIX","CBOE VIX",15.41,0.33,2.19,"0.0,9.5 2.3,4.4 4.6,4.0 6.9,2.0 9.3,11.1 11.6,13.6 13.9,13.4 16.2,16.0 18.5,12.1 20.8,10.2 23.2,13.4 25.5,8.6 27.8,8.7 30.1,7.5 32.4,7.3 34.7,11.6 37.1,10.8 39.4,12.8 41.7,12.5 44.0,11.2",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":14,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",230.48,-6.99,-2.94,"0.0,16.0 7.3,12.8 14.7,8.8 22.0,2.4 29.3,2.0 36.7,4.3 44.0,13.3",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":54,"sparkline":91,"date":5},"AAPL","Apple Inc",340.43,3.76,1.12,"0.0,12.3 7.3,16.0 14.7,11.3 22.0,12.4 29.3,11.4 36.7,7.2 44.0,2.0",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":14,"sparkline":98,"date":5},"TSLA","Tesla Inc",375,-2.81,-0.74,"0.0,15.6 7.3,16.0 14.7,7.3 22.0,3.0 29.3,2.0 36.7,3.5 44.0,5.0",[100,105,110,115,120,125,130,134,139,144,149],{"name":101,"etf":102,"change":103,"price":104,"is_up":14},"Technology","XLK",-1.79,197.78,{"name":106,"etf":107,"change":108,"price":109,"is_up":54},"Financials","XLF",0.89,54.23,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.39,168.16,{"name":116,"etf":117,"change":118,"price":119,"is_up":54},"Consumer Cycl","XLY",0.31,111.7,{"name":121,"etf":122,"change":123,"price":124,"is_up":54},"Consumer Staples","XLP",2.11,83.42,{"name":126,"etf":127,"change":128,"price":129,"is_up":54},"Energy","XLE",2.97,65.24,{"name":131,"etf":132,"change":74,"price":133,"is_up":54},"Industrials","XLI",168.4,{"name":135,"etf":136,"change":137,"price":138,"is_up":54},"Materials","XLB",0.59,49.27,{"name":140,"etf":141,"change":142,"price":143,"is_up":54},"Real Estate","XLRE",0.69,40.85,{"name":145,"etf":146,"change":147,"price":148,"is_up":14},"Utilities","XLU",-0.19,41.07,{"name":150,"etf":151,"change":152,"price":153,"is_up":54},"Comm Services","XLC",0.73,112.07,[155,160,165,170],{"ticker":156,"name":157,"price":158,"change":159,"is_up":14},"SPY","SPDR S&P 500 ETF",773.97,-0.42,{"ticker":161,"name":162,"price":163,"change":164,"is_up":14},"QQQ","Invesco QQQ Trust",747.58,-1.34,{"ticker":166,"name":167,"price":168,"change":169,"is_up":54},"DIA","SPDR Dow Jones ETF",511.65,0.12,{"ticker":171,"name":172,"price":173,"change":174,"is_up":14},"IWM","iShares Russell 2000",277.63,-0.03,{"ticker":4,"count":176,"articles":177},20,[178,184,190,196,202,208,214,220,226,232,238,243,248,252,258,263,268,273,279,285],{"title":179,"link":180,"pubDate":181,"description":182,"source":183},"A trial missed key goals, yet FDA recommends a meeting on Rezolute's drug - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwAFBVV95cUxNZVdDNC1wakZmZm5Ma19XejhlY0xES2pkOTRMTUxIdWExUlFmZjdLbjZGZjVSWk1yUWVER1A1SjgyZDBacFcyclBEQmJjaU5qUHp6M1dncm5IYmhER2RUTldWYjhWbUFkV3NOdnd0NERLN0V0Qy14YWRLcV8xLTUxTFpQY3B1S082ZU50RTRiNWZ4OGRjblRfNFZMTUVvLXN5ZkpONUtxMk1aUXpmVnBLcjFnejdzeEVPRmQwUTJna0Q?oc=5","Mon, 05 Oct 2026 11:00:00 GMT","A trial missed key goals, yet FDA recommends a meeting on Rezolute's drug Stock Titan","Stock Titan",{"title":185,"link":186,"pubDate":187,"description":188,"source":189},"RZLT Initiated Coverage by Lake Street -- Price Target Announced at $9.00 - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqwFBVV95cUxQQ3JqUjJnWTJyMExTeFhVQjRscE9mZmlmSG9FM0JQVmZqVTJJSmxkaHc0c3B3MHYwa3QwSE16QmNPaENUREJWZWotaVFwTUkzUVRqcU1zYmxjblNOOGN0RExMZnhGSFgyck53RmdEVFVBdWRXVEJoelVwS2s1al83SVJpVWZrZERMczVZNlh5Z2lBMklSQ0dVMG9CSEF2a294U01YVzc0UndYSjQ?oc=5","Wed, 30 Sep 2026 16:20:23 GMT","RZLT Initiated Coverage by Lake Street -- Price Target Announced at $9.00 GuruFocus","GuruFocus",{"title":191,"link":192,"pubDate":193,"description":194,"source":195},"Rezolute Gets FDA Nod For Pre-BLA Meeting Despite Phase 3 Miss — Retail Expects ‘Huge Rerating’ - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMijwFBVV95cUxOWTBDRVU2MEM0bWxKcUpXaERFRnRVQmpPckUxZmVTWFJYRGlmclVEbjhuQkRmeXBPY1Ftbi1xek9aM0Z2M0dBUkVLMDhrUUh0cmhmWkFSU3ZkcnRQdmNRdmt1UEJjQ1RRZlBFb0duNDVvSXB5OE5NSG5wSFV0NHVjOXhVSVlNNkp2TG4yZXF5RQ?oc=5","Mon, 05 Oct 2026 12:58:30 GMT","Rezolute Gets FDA Nod For Pre-BLA Meeting Despite Phase 3 Miss — Retail Expects ‘Huge Rerating’ Yahoo Finance","Yahoo Finance",{"title":197,"link":198,"pubDate":199,"description":200,"source":201},"These stocks are moving in today's after hours session - ChartMill","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqAFBVV95cUxQMXBxVHg0OHhFR1d1bFBpUWNEczZUYTh5VGlsVzlEMmxQSFBBWmx3S2NtRkI4N3NJZF9BLVBaNUVyRy1EdnJLaFJLSkJHWFJLWEc2N0twc1JWNnA3YS1Jcm5jTFNINkxDei1OMkh0WlV1ZVR4UV81cExRSGgyLW5FejltTHZxY0M0TDI3dmFZMGxaMHRuamwya2l0OUpQR3BjZ0d3RmRlYkI?oc=5","Mon, 05 Oct 2026 21:00:00 GMT","These stocks are moving in today's after hours session ChartMill","ChartMill",{"title":203,"link":204,"pubDate":205,"description":206,"source":207},"Rezolute upgraded at Cantor on pre-BLA meeting for ersodetug - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikgFBVV95cUxPQUt3TUZzOVdTLXdfUUdpNEhuMmN1MFA4QTA3d3NYSVVaODQtUVVQZkVTby1XTEZwNU9QdkhtaGpwUi1ja3Jvd1RFaFRtbnllQmpYcUNwby0xMHZMeHpFR09IZzBIemlFWVpDZ290dUtXUmpKQ0RPVzdCQ1c0NGtWaXJJcERFbVhIVHVjd2VLN29ydw?oc=5","Tue, 06 Oct 2026 19:26:21 GMT","Rezolute upgraded at Cantor on pre-BLA meeting for ersodetug Seeking Alpha","Seeking Alpha",{"title":209,"link":210,"pubDate":211,"description":212,"source":213},"FDA Recommends Meeting for Rezolute Drug for Rare Blood Sugar Disorder Despite Missed Endpoints - Benzinga","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi3AFBVV95cUxQUDVUOUotU1ZERVdnQjJ6dDBfU2pyZ3VtTU43R3pIZkdaeWxiaGZqZnNlenlvajRpbWtTUzVzS2p0bnZQbU1nNzNncU9BTGdaOUVxeWpmNnVRUkFNMHRMaXJaRWtYSEd1LWRKSmJjY25VY0ZyUUl2REVjSHpnWU1OekZaOWVoVm9uY0VQRjVTOHozQXl0My1SS25FQnR2d3BtMUZvcElTOG1mSjNRa3V5VkxHT1VlbGZmQXZGakh5Z3F5emJ1YXRZQ2JET1pubFF3VEJSU1VneFRGUGNU?oc=5","Mon, 05 Oct 2026 15:53:43 GMT","FDA Recommends Meeting for Rezolute Drug for Rare Blood Sugar Disorder Despite Missed Endpoints Benzinga","Benzinga",{"title":215,"link":216,"pubDate":217,"description":218,"source":219},"H.C. Wainwright raises Rezolute stock price target on trial data - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxPUEhWOGEwdkZXOWVrcGk4NVJxU3hGbWc5ZWlrUmpEcUlYM0pINHhXYmVwWUhwNDJFcXk4VHlRcUFuVE5SZDdxeXcxRGI3X1dVX0lYcmNmc2loTzF2VWk3QVVfWGVLU243c3JDYnAtWVV5Xy1rU2k5VUtudTJXMDRiWTFtalk3LVZEQWF0b3hlY3dMU09uVWNnX3hvMFdudE9HandoTndCVU1KLU45ZU9rSm44MW5Mb3o3bENSMDJscw?oc=5","Mon, 28 Sep 2026 12:15:28 GMT","H.C. Wainwright raises Rezolute stock price target on trial data Investing.com","Investing.com",{"title":221,"link":222,"pubDate":223,"description":224,"source":225},"Craig-Hallum Upgrades Rezolute(RZLT.US) to Buy Rating, Raises Target Price to $7 - Moomoo","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirgFBVV95cUxNdXpsc1ZhbFZGOXR4TzZwLXh4bWQzNmlIQW1BN2kyeVFiNlcyTjJsemdMNks3RTQ2QjZ2Q1V0eWNwbm0tZGRRV1lOOW0zNVBhS1B1eExZbTlNbHFIWnkzMEhtVWl3WUVTY2xzVHUyNkhWcnhpNGpqRWRSMHcxYzR3OXdFSlllc2FhcTBfSkFCTDlZQmZ0VHBSd290MDVUWE9sUDJMOGlkRVp4NnF6bXc?oc=5","Tue, 29 Sep 2026 11:33:00 GMT","Craig-Hallum Upgrades Rezolute(RZLT.US) to Buy Rating, Raises Target Price to $7 Moomoo","Moomoo",{"title":227,"link":228,"pubDate":229,"description":230,"source":231},"Rezolute Inc (NASDAQ: RZLT) Share Price, RZLT Stock News, RZLT Share Price & Updates - Kalkine","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiVkFVX3lxTE5TeU8yWDBZN3dOc1NQNUo2b1JwdWQ5M1BqZmZHYng2SmFYSjFYcDV3MnAtSjFKTDRRbnk4bWdhNm14dHQzRW80dk1vNGd4N3RYSmc2bk1R?oc=5","Fri, 02 Oct 2026 20:02:00 GMT","Rezolute Inc (NASDAQ: RZLT) Share Price, RZLT Stock News, RZLT Share Price & Updates Kalkine","Kalkine",{"title":233,"link":234,"pubDate":235,"description":236,"source":237},"McDonald’s Stock Draws Fresh Target Cuts – Wells Fargo Says Analyst Day Message Is Still ‘Hard To Digest’ - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi-gFBVV95cUxPNWoxVnBpUU5XYlI3d1kxeDNWMFF5Ulk2eFdHOGRUVl9NZzhmY0hMRi05Zk01VHNGRm1lWHdHT2lJWE1NM1pKWmVWTjNiSWlnN3ZfVFhxNGU3TTdLR1NwaWNCQk1PcmtwZ0NrU2NkT0dMdjdWWDZKYzVyZEdIS2RBWkRBd1ZNanNkSGlEdTF2RXl3ZWVLbmtHM3ktNUp1d1R2ZHltVWluZFBxYTFnaXpHcTVXRkw3aWt1cklzVFJfRzJuSDlINGJOS3k0WWJZTWt6V01TSFdnUTltUXlBejlCTENsRVY2WkNuYk12SmozR1BKRmZyd1pjRWFB?oc=5","Mon, 05 Oct 2026 11:17:52 GMT","McDonald’s Stock Draws Fresh Target Cuts – Wells Fargo Says Analyst Day Message Is Still ‘Hard To Digest’ Stocktwits","Stocktwits",{"title":239,"link":240,"pubDate":241,"description":242,"source":183},"A December 2 shareholder vote could expand Rezolute (RZLT)'s authorized common shares. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirwFBVV95cUxOUkRRNUtGdGR4X2kxYnc5WnZlckhEV2hnaXNONTh4bDNSekxwUkxqdDRzcy03QnZNQzdTeWVTd2FPbVR2OFVHQW5rbWxFZUw1MFJGOXRUYUZtNExrSWVJYWVuSldGSFdBSjdiZ3ViWVBKWXkxOGJEbjNvaTd5WnBZR3lhRlFOVG1TNXBkSUZxVDZIVVU4RW14Y2J4Vk1lVThGRURLTkZFS3BCcUhOeWpR?oc=5","Mon, 05 Oct 2026 07:00:00 GMT","A December 2 shareholder vote could expand Rezolute (RZLT)'s authorized common shares. Stock Titan",{"title":244,"link":245,"pubDate":246,"description":247,"source":189},"RZLT Maintained by Lake Street -- Price Target Raised to $12.00 - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMingFBVV95cUxObURXTDJrNFNWRnlPc2NsNXdQVF9MdmhJNm90cTlxaC10YzFsTXNWYU9aN2x0YWVYdXJnMmdYLUo2d2dFYVlVRlU4bC1EUUU5RGxIdWpkckZiM2hkOUtUV1ZvSlhlZTNDUnlHaVNQV2hSenk1aEY1OTZxOVhFSWxSamJMLUhiTU03NWZsV1Q5UjZMMjFGbFRfYXlvNjJOZw?oc=5","Tue, 06 Oct 2026 22:28:13 GMT","RZLT Maintained by Lake Street -- Price Target Raised to $12.00 GuruFocus",{"title":249,"link":250,"pubDate":235,"description":251,"source":237},"NVTS Stock In Spotlight Today Following Microchip Collaboration – Everything That Investors Need To Know - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi-gFBVV95cUxNTHR4RG5JUHJDZkI4WW1rOG1iTklnLXlPWWh6SmFwdEVZeVlrMHI0Q3F3QU5xcHBrN3l2RGdhUXV1cUFZN1RHMnNqamJkUmJ3Q2ZPN1VXMnE3REZKd2xBU25NT3ZhT19aZ2RYcV9VUVJRQ09ZS054bzNsbFVXS3hOVTNSZGdERTRtcElVQmh1TG1XR2JOM01NVnBiY0FGbTg2QWNXMUdwd1I3TkRmRVdtdEFvWnVHRTU4cTJSeXJkRktyOERoR3RYUm5Sd1BNdkxxYXBJXzI4eWF0ZzR1dXJCclNZTHI2Vzd4VVdvOWRuaWJfdk5ENllrclhR?oc=5","NVTS Stock In Spotlight Today Following Microchip Collaboration – Everything That Investors Need To Know Stocktwits",{"title":253,"link":254,"pubDate":255,"description":256,"source":257},"Citizens raises Rezolute stock price target on FDA feedback By Investing.com - Investing.com Nigeria","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxQYmpGd2UwSkVSVTVscDBFN0c2M1FNRzZuRHFGNmptRUZHOTlaRkJzS3BGQ3dWbFVoVWk5N1pkb0JJbEx5aFlTYnVRTUw4VHlUREFZNG03c1lua0IyZkpsb2l2SENDaUZNd0pIQ0dxZTY3ZE9WaGhVZDhqUURDTTc0UXp6RmRUVG9aN0pabkZBVUI5VTFfSzU2Y0NGdnl2Nm9lMlJiMXkzUmozdGFUT3diNjRfMHlQVHhoS0QxLQ?oc=5","Tue, 06 Oct 2026 21:17:30 GMT","Citizens raises Rezolute stock price target on FDA feedback By Investing.com Investing.com Nigeria","Investing.com Nigeria",{"title":259,"link":260,"pubDate":261,"description":262,"source":189},"RZLT Upgraded by Craig-Hallum -- Price Target Raised to $7.00 - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimgFBVV95cUxQUUlrekpmUWVFQTNnVFBPeVFCZzR0ZUsyTGZDVUdmYjNITUo3M3g3QUY0dkYyNmtaQnpjZFM5VE1VLTJFTXhnNFY0WkZxcXZMYm5FT09xeTlYTHNITVpZR3RzQnBYLVZhNUs3UUY1bV94OVdhUlNldm5aQTFrRk1tdDNZaUJWbUMzUElBeUx3U0QxbDFIQlhlSlNR?oc=5","Tue, 29 Sep 2026 13:21:35 GMT","RZLT Upgraded by Craig-Hallum -- Price Target Raised to $7.00 GuruFocus",{"title":264,"link":265,"pubDate":266,"description":267,"source":189},"Rezolute (RZLT) Upgraded to Overweight by Cantor Fitzgerald on E - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiugFBVV95cUxObXZTLUhEeWgzN19XZXdtTDQ4RTJER0lITGd5Mmk5UmhVNTI5RGNzMEJHYjVYeko5dEJJVFJUUmFEMkFRb0pNVUNweWZheUk4ZEhIcVc4WkktN0pYcG5GVTZ6MGUxNnluRTJLT1J1N05rTkYwYzZNdmlHWTBJc2l5djNPS0hxSVlSRUtLYW90RUc4bGgzcE1VQVFPM1g3SHdhRWg1ZjhhbFNpRnpRanUzd1ctcGgwR1B1eXc?oc=5","Tue, 06 Oct 2026 20:31:40 GMT","Rezolute (RZLT) Upgraded to Overweight by Cantor Fitzgerald on E GuruFocus",{"title":269,"link":270,"pubDate":271,"description":272,"source":219},"H.C. Wainwright reiterates Buy on Rezolute stock, $10 target - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxOdV91Sjg4Q2E5WDY5TzZEXzlaQzB3dzZkbFlIOWZGc1RxUFhaY0RNeVRNSlU4LWtQY2V0bndlMDllVlNoRERoUzlwcmNkTkhRZkQyMFhHeEZqd25hOFpPSUpCWnlsWDFnSGZRRlNieEVZZHlLajZPU1dqVjZBeUwyc2F0S1JZSEdBcGJUODZ5VDZXUWU3c3BxX3ZhUUx6UmNxaGVUd2lBb1RGQW9DdEpNLVhCZXF2M0U?oc=5","Tue, 06 Oct 2026 12:07:06 GMT","H.C. Wainwright reiterates Buy on Rezolute stock, $10 target Investing.com",{"title":274,"link":275,"pubDate":276,"description":277,"source":278},"Citizens maintains Market Outperform rating on Rezolute, $15 price target - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizgFBVV95cUxQM0RCRGQxODJFVV9UZWJZazk1MWdfNHFkaDl2RUVoRndIZEZJZkZQbHBIUnI4aWVmZlJHYW53Zl9BNWctRUZCVU9xNXdWMm85RGd6eHhrQWdVWWRDUUpITUNGeDBIS0pyYVlXdnowUUZqTE04RGw1cGY4MTliMF9JV0Q2aXotZ2lXakdqTUdSck1aU18wVWxnWlJZTjNFU0RSX1Y2dEFBcnJoYWFRaGpFM2x5VmJpZDhxYWJMdUM0OER4TWRvYUhDUlRUVDRxdw?oc=5","Tue, 06 Oct 2026 12:50:25 GMT","Citizens maintains Market Outperform rating on Rezolute, $15 price target TradingView","TradingView",{"title":280,"link":281,"pubDate":282,"description":283,"source":284},"RZLT261120C00007500 interactive stock chart | RZLT Nov 2026 7.500 call stock - Yahoo Finance Australia","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiZEFVX3lxTE1kbmQ1RlRGbjU4X0p5WVN0a3ZuQXdacTZ6VWtCeElzR0REa29PUkYtQVR1eEZJNnZuVk5nX2hRM3A5WEY4WkVqZlZtTjJLUTR4S2phMTNuQnZ2X1Njc3VvX3lvcEY?oc=5","Mon, 05 Oct 2026 16:02:11 GMT","RZLT261120C00007500 interactive stock chart | RZLT Nov 2026 7.500 call stock Yahoo Finance Australia","Yahoo Finance Australia",{"title":286,"link":287,"pubDate":288,"description":289,"source":290},"Rezolute says FDA recommends pre‑BLA meeting after congenital HI trial miss - Mugglehead Investment Magazine","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMidEFVX3lxTE84RmJpbW9kSEZXUWcybkNKTUIzR05NcjZ4MmdVRlYwTWhJVzBsMk1kSGZyMUkwQk8xUTZidWR3aFBVbHplOVlUdXFUTUxycEZUc1EzdHdwNE5SWU5ZSkV6QlhGS0xGODEzb1NhOHc0QkptRldp?oc=5","Tue, 06 Oct 2026 07:40:51 GMT","Rezolute says FDA recommends pre‑BLA meeting after congenital HI trial miss Mugglehead Investment Magazine","Mugglehead Investment Magazine"]